Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

BeiGene, Hengrui Among China Firms Flexing New Oncology Muscle At ASCO

Thu, 06/06/2019 - 8:25pm

In its bid to facilitate novel treatments for some of its most prevalent cancers, China is also poised to make...

      Related Stories 

Ninlaro Failure Leaves Little In AL Amyloidosis Pipeline

Thu, 06/06/2019 - 6:10pm

Takeda proteasome inhibitor stumbles at Phase III among potential first therapies for a deadly form of amyloidosis.

      Related Stories 

BIO 2019 Notebook: M&A Soars, Lartruvo Lookback, BIO Vs. ASCO

Thu, 06/06/2019 - 1:57pm

News and views from day four of the BIO International Convention: emerging company M&A deals nearly double in 2018; former...

      Related Stories 

AZ’s Calquence Hits Endpoint In Second CLL Phase III Study

Thu, 06/06/2019 - 7:29am

The results move AstraZeneca closer to challenging AbbVie and Johnson & Johnson’s blockbuster Imbruvica in the blood cancer market.

      Related Stories 

Aceto Claims Aurobindo Caused Its Collapse

Thu, 06/06/2019 - 7:24am

Aceto has blamed Aurobindo for its downfall, alleging a series of calculated and deceitful actions that have critically wounded the...

      Related Stories 

With New Leadership, Roche Goes Back To Basics At ASCO

Wed, 06/05/2019 - 6:59pm

In a time of internal transition, Roche emphasized its deep roots and broad pipeline at its annual event alongside the...

      Related Stories 

BIO 2019 Notebook: Merck On Finding The Right Balance, Sandoz On The Next Wave Of Biosimilars, NORD On Patient Engagement

Wed, 06/05/2019 - 4:32pm

News and views from day three of the BIO International Convention: Merck’s Frazier champions both social justice and capitalism; ...

      Related Stories 

Bristol Unveils Post-Celgene Leadership Team, With Big R&D Changes

Wed, 06/05/2019 - 12:45pm

Novartis's Hirawat will join the company as chief medical officer, while Celgene's Vessey will head early research. Bristol's current chief...

      Related Stories 

Novartis' Drug Discovery Head Jay Bradner On What NIBR Is Investing In

Wed, 06/05/2019 - 10:14am

NIBR's Bradner talked to Scrip about how AveXis turbo-charged Novartis' gene therapy development, investing in inflammasome research, and partnering nimbly...

      Related Stories 

How GenomiQa Hopes To Power Improved Outcomes In Cancer

Wed, 06/05/2019 - 9:09am

Colin Albert, CEO of genomiQa, outlines the potential and benefits of whole genome analysis in cancer therapy and research. Expansion...

      Related Stories 

Sanofi Pasteur Head: Global Flu Vaccination Rates 'Dangerously Low'

Wed, 06/05/2019 - 9:07am

The head of Sanofi Pasteur tells Scrip more countries need to emulate the UK’s relatively high flu vaccination level, and...

      Related Stories 

Spotlight on Q1 Pharma M&A Merry-Go-Round

Wed, 06/05/2019 - 7:48am

Q1 2019 saw a jump in merger and acquisition activity. Informa’s Biomedtracker has cast an analytical eye on three of...

      Related Stories 

ASCO Review: Progress Is Where You Find It

Tue, 06/04/2019 - 11:35pm

In another year roundly critiqued as being “quiet” on major clinical advances, the American Society of Clinical Oncology annual meeting...

      Related Stories 

Pages